The federal R&D Tax Credit (IRC Section 41) provides a credit of up to 20% of qualified research expenditures above a base amount — in practice, most SMBs claim ~6–8% of qualifying R&D spending. Available to businesses developing new or improved products, processes, software, or formulas. Startup businesses with no tax liability can apply the credit against payroll taxes.
The Research and Experimentation (R&E) Tax Credit was made permanent by the PATH Act of 2015 after decades of temporary renewals. The credit applies to Qualified Research Expenditures (QREs): wages for employees performing qualifying research, supplies used in research, and 65% of contractor payments for research conducted in the US. To qualify as 'qualified research,' activities must meet a four-part test: (1) Permitted purpose — developing a new or improved product, process, technique, formula, or computer software intended for sale or use in trade or business. (2) Technological in nature — relying on physical, biological, engineering, or computer science principles. (3) Elimination of uncertainty — attempting to eliminate technical uncertainty about development or improvement. (4) Process of experimentation — testing alternatives through simulation, modeling, systematic trial and error, or other scientific methods. The two calculation methods: (1) Regular Credit — 20% of QREs exceeding a calculated base amount (3-year fixed-base percentage × average annual gross receipts for prior 4 years). Complex but often yields a larger credit. (2) Alternative Simplified Credit (ASC) — 14% of QREs exceeding 50% of average QREs for the prior 3 years. Simpler; most SMBs use ASC. If no prior-year QREs, ASC = 6% of current QREs. For startups (under 5 years of gross receipts and under $5M annual gross receipts), the Protecting Americans from Tax Hikes Act (PATH Act) allows up to $500,000/year of R&D credit to offset federal payroll taxes (FICA employer share) rather than income taxes — critical for pre-profit companies. The payroll offset increased to $500K starting 2023 (from $250K previously) under the Inflation Reduction Act.
Any US business that develops or improves products, processes, software, or formulas can potentially qualify — including manufacturers, software companies, biotech, food processors, engineering firms, and specialty contractors. The research doesn't need to be groundbreaking; incremental process improvements and new feature development for internal software qualify. Activities that do NOT qualify: market research, management studies, post-commercial production quality control, social science research, and funded research paid for by another party.
A tax credit reduces your tax liability dollar-for-dollar — a $50,000 R&D credit reduces taxes owed by $50,000. A deduction reduces taxable income — a $50,000 deduction reduces taxes by $50,000 × your marginal tax rate (e.g., $16,000 at 32%). Credits are generally more valuable than equivalent deductions. However, IRC Section 174 (as amended by TCJA) requires businesses to amortize R&D expenses over 5 years (15 for foreign R&D) starting 2022 — interplay between the deduction and credit requires careful tax planning.
No. Most qualifying R&D happens in ordinary business settings — a software developer's desk, a manufacturer's production floor, a food company's test kitchen. What matters is that the activity meets the four-part test: business purpose, technological basis, uncertainty elimination, and systematic experimentation. Documentation is critical — timesheets, project records, technical notes, and payroll records support the credit in audit. Contemporaneous documentation is far stronger than reconstructed records.